1 completed, 1 unknown. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Unknown 1 |
Follow Scopolamine: new trials by email Literature Review of Scopolamine trials Research Report on Scopolamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nebulizer Delivery of Intranasal Scopolamine Scopolamine, Placebo - Scopolamine, Motion Sickness | Phase 1 | Completed | Dartmouth-Hitchcock Medical Center | 14 | 2022-01-24 | 2025-08-28 |
| The Safety and Effectiveness of Cholinergic Receptor Block Therapy in the Treatment of ALS Scopolamine, atropine, edaravone and dexmedetomidine, Edaravone - Amyotrophic Lateral Sclerosis, Respiratory Function | Phase 2 | Unknown | Ruijin Hospital | 30 | 2020-11-01 | 2020-10-14 |
Amyotrophic Lateral Sclerosis (1) · Motion Sickness (1) · Respiratory Aspiration (1)
Pathological Conditions, Signs and Symptoms (2) · Central Nervous System Diseases (1) · Metabolic Diseases (1) · Motor Neuron Disease (1) · Nervous System Diseases (1) · Neurodegenerative Diseases (1) · Neuromuscular Diseases (1) · Nutritional and Metabolic Diseases (1) · Pathologic Processes (1) · Proteostasis Deficiencies (1) · Respiration Disorders (1) · Respiratory Tract Diseases (1) · Signs and Symptoms (1) · Spinal Cord Diseases (1) · TDP-43 Proteinopathies (1)
Scopolamine (2) · Atropine (1) · Dexmedetomidine (1) · Edaravone (1)
Dartmouth-Hitchcock Medical Center (1) · Ruijin Hospital (1)
China (1) · United States (1)
Jay C Buckey, Ph.D (1) · Jun Liu, Professor (1)